FutureLink Boston 2025 Reinforces TraceLink's Leadership in Supply Chain Orchestration and Innovation

May 06, 2025 10:09 PM IST | By Cision
 FutureLink Boston 2025 Reinforces TraceLink's Leadership in Supply Chain Orchestration and Innovation
Image source: Kalkine Media

BOSTON, May 7, 2025 /PRNewswire/ -- TraceLink, the largest end-to-end digital network platform for intelligent supply chain orchestration, successfully hosted FutureLink Boston 2025, bringing together more than 150 attendees ranging across senior executives, industry experts, and supply chain technology innovators from across the end-to-end healthcare and life sciences ecosystem. Now in its ninth year, FutureLink remains the only industry event focused exclusively on safeguarding and advancing the digital transformation of the end-to-end life sciences and healthcare supply chain.

With an agenda specifically designed to bridge the gap between strategic vision and operational execution, FutureLink Boston offered a unique opportunity for attendees to gain direct insight from the companies shaping the future of life sciences and healthcare. Over three days, attendees explored how digitalization, real-time supply and demand data, and generative AI are transforming supply chain operations and delivering meaningful impact to patients worldwide.

"With representation from every corner of the supply chain, FutureLink is unmatched in its ability to bring the healthcare and life sciences industry together to transform vision into action," said Shabbir Dahod, President and CEO of TraceLink. "It's the only forum where innovation at the intersection of supply chain digitalization, regulatory readiness, and agentic orchestration converge to drive measurable impact—all powered by an integrate-once digital business network that doesn't exist anywhere else in the world. That network is the foundation for building intelligent, linked, and patient-centric supply chains, and FutureLink is one of the ways we bring that leadership to life."

Driving Digital Transformation Across the Industry
With 26 industry speakers and nearly 50 total sessions, the event showcased how customers are using the TraceLink Orchestration Platform for Universal Solutions (OPUS) to orchestrate supply chain relationships, digitalize critical business processes, and supply generative AI models and enterprise systems with real-time supply chain data. A special focus was placed on:

  • Leveraging DSCSA and serialization investments as a foundation for digital transformation.
  • Ensuring DSCSA readiness among more than 5,000 companies and 650 TraceLink DSCSA customers already deploying more than 10,000 EPCIS links.
  • Using TraceLink Multienterprise Information Network Tower (MINT) to exchange more than 40 commercial transactions, including purchase orders, inventory balances, advanced ship notices, and invoices, to build intelligent orchestration layers on existing track-and-trace infrastructure.
  • The need for collaborative trading partner execution for critical processes such as DSCSA compliance exception management through solutions like TraceLink Process Orchestration for Empowered Teams (POET).
  • Fueling generative AI initiatives with foundational, real-time supply chain data to create agentic orchestration experiences.
  • Leveraging the open OPUS service, solution, and technology partner ecosystem for digital transformation acceleration, as evidenced by the presence of 19 different solution and technology partner companies at the conference.

FutureLink Boston set the stage for what's next in global supply chain transformation. This fall, the momentum continues in Europe. Registration is now open for FutureLink Barcelona—join us October 6-8, 2025 to collaborate with industry leaders, explore breakthrough innovations, and accelerate your journey toward a more agile, intelligent, and patient-centric supply chain.

About TraceLink
TraceLink Inc. is the largest end-to-end intelligent supply chain platform for life sciences and healthcare, enabling end-to-end orchestration by connecting more than 291,000 healthcare and life sciences entities through its B2N Integrate-Once™ network. Leading businesses trust TraceLink to deliver complete global connectivity, visibility, and traceability of healthcare products, ensuring that every patient gets the medicines they need when needed, safely and securely.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalized advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.

Sponsored Articles


We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.